Medical Research
Mission Bio: Pioneering cancer pathologist Jorge Reis-Filho’s lab at Memorial Sloan Kettering Cancer Center to develop best practices integrating Tapestri single-cell multi-omics capabilities SOUTH SAN FRANCISCO, March 1, 2022 — Mission...
2022/027 from 11/02/2022 - Following surgery, patients with breast cancer are faced with the question of whether additional chemotherapy is necessary and really effective. It is important that these women do not receive too much treatment –...
In honor of World Cancer Day, The Desmoid Tumor Research Foundation is celebrating the success of their virtualized tumor board program enabled through the OncoLens platform Atlanta, GA: In honor of World Cancer Day on February 4th, The...
Vabysmo (faricimab-svoa) targets and inhibits two disease pathways that drive wet age-related macular degeneration (AMD) and diabetic macular edema (DME). Vabysmo is the only injectable eye medicine approved simultaneously in the US for wet...
Artificial intelligence: A promising frontier in bladder cancer diagnosis and outcome prediction Abstract Bladder cancer (BCa) is the most common malignancy of the urinary tract and the most expensive malignancy to treat over the...
January 27, 2022 – The CONDOR consortium, led by Pr. Antoine Italiano of the Bergonié Institute (Bordeaux, France) is one of the 17 national awardees in the fifth call for projects in Hospital-University Research in Health (RHU5),...
